Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
26 26 Search
2025
Development of therapeutic cancer vaccines based on cancer immunity cycle
Frontiers of Medicine
2025
Loss of ARID1A leads to a cold tumor phenotype via suppression of IFNγ signaling
Scientific Reports
2025
T cells in the microenvironment of solid pediatric tumors: the case of neuroblastoma
Frontiers in Immunology
2025
Bioinformatics analysis of intrinsic drivers of immune dysregulation in multiple myeloma to elucidate immune phenotypes and discover prognostic gene signatures
Scientific Reports
2024
Biomedical Aspects of Solid Cancers
2024
Single‐cell RNA sequencing in pediatric research: Focusing on differentiation trajectories and immune microenvironment of neuroblastoma
Pediatric Discovery
2024
CD20highCD138low tumor-infiltrating lymphocytes predominantly related to cytokine‒cytokine receptor interactions are associated with favorable outcomes in neuroblastoma patients
Heliyon
2024
Targeting to Overexpressed Receptor in Colon Cancer: A Review
The International Journal of Gastroenterology and Hepatology Diseases
2023
Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches
Frontiers in Immunology
2023
Biological Insight and Recent Advancement in the Treatment of Neuroblastoma
International Journal of Molecular Sciences
2023
Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus
Cancer Pathogenesis and Therapy
2023
Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma
Journal of Molecular Medicine
2022
Opsoclonus‐myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity
Pediatric Blood & Cancer
2022
The immune cell atlas of human neuroblastoma
Cell Reports Medicine
2022
Tumoral heterogeneity in neuroblastoma
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
2022
Upregulation of CD3ζ and L‐selectin in antigen‐specific cytotoxic T lymphocytes by eliminating myeloid‐derived suppressor cells with doxorubicin to improve killing efficacy of neuroblastoma cells in vitro
Journal of Clinical Laboratory Analysis
2022
Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma
Cells
2021
The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
European Journal of Cancer
2021
Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets
Frontiers in Oncology
2021
Targeted elimination of myeloid-derived suppressor cells via regulation of the STAT pathway alleviates tumor immunosuppression in neuroblastoma
Immunology Letters
2021
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs
International Journal of Molecular Sciences
2021
Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma
Chinese Medical Journal
2020
A new clinical prognostic nomogram for liver cancer based on immune score
PLOS ONE
2020
The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives
Cancers
2020
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming
Cancers
Additional cited-by details will be shown when available from Crossref